Market revenue in 2023 | USD 541.7 million |
Market revenue in 2030 | USD 1,042.8 million |
Growth rate | 9.8% (CAGR from 2023 to 2030) |
Largest segment | Next generation sequencing |
Fastest growing segment | Next Generation Sequencing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Next Generation Sequencing, QPCR & Multiplexing, LOAC & RT-PCR, Protein Microarrays, DNA Microarrays |
Key market players worldwide | Johnson & Johnson, Illumina Inc, Novartis AG ADR, Roche, Koninklijke Philips NV, Qiagen NV, Agilent Technologies Inc, Abbott Laboratories, Thermo Fisher Scientific Inc, GE HealthCare Technologies Inc Common Stock |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to next generation cancer diagnostics market will help companies and investors design strategic landscapes.
Next generation sequencing was the largest segment with a revenue share of 36.88% in 2023. Horizon Databook has segmented the Brazil next generation cancer diagnostics market based on next generation sequencing, qpcr & multiplexing, loac & rt-pcr, protein microarrays, dna microarrays covering the revenue growth of each sub-segment from 2018 to 2030.
Concentration of more investments for sequencing and data analysis services in the South-eastern region of the country as a consequence of availability of resources is anticipated to propel growth of this region in diagnostics sector.
Additionally, technology boom in Sao Paulo with respect to computer resources and web development is expected to impact the growth in data analysis segment of NGS technology.
The Brazilian population Based Registry (PBCR) with its twenty establishments across the country has analyzed that there were high cancer incidences between 92 to 220 children/adolescents per 100,000, and children between the ages of 1-4 years.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil next generation cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil next generation cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account